Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Expert Opinion on Emerging Drugs|May 21, 2009
Emerging drugs for respiratory syncytial virus infectionWieslawa Olszewska, Peter OpenshawFuture Microbiology|October 1, 2011
Redefining latent tuberculosisSaranya Sridhar, Katrina Pollock, Ajit LalvaniCurrent Opinion in Virology|March 24, 2012
Contribution of cytokines to pathology and protection in virus infectionAndreas Wack, Peter Openshaw, Anne O'GarraCurrent Topics in Microbiology and Immunology|June 15, 2022
Controlled Human Infection Challenge Studies with RSVPete Dayananda, Christopher Chiu, Peter OpenshawExpert Review of Respiratory Medicine|December 7, 2013
Interferon-gamma release assays for tuberculosis: current and future applicationsMuhunthan Thillai, Katrina Pollock, Manish Pareek, et al.Expert Review of Vaccines|March 26, 2011
Hot topics in the prevention of respiratory syncytial virus diseaseMaximillian S Habibi, Sanjay Patel, Peter OpenshawCell|September 17, 2021
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variantsMuge Cevik, Nathan D Grubaugh, Akiko Iwasaki, et al.Nature Reviews. Microbiology|June 7, 2012
The microbiology of asthmaMichael R Edwards, Nathan W Bartlett, Tracy Hussell, et al.European Journal of Immunology|July 11, 2012
Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adultsSaranya Sridhar, Shaima Begom, Alison Bermingham, et al.The Journal of Infectious Diseases|March 9, 2019
The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysisTing Shi, Andrew Arnott, Indre Semogas, et al.Pageof 4